NCT01666405

Brief Summary

The purpose of this study is to determine the effectiveness of percutaneous tibial nerve stimulation (PTNS) therapy with the Urgent® PC Neuromodulation System (Uroplasty, Inc., Minnetonka, MN, USA) for the treatment of fecal incontinence (FI).

Trial Health

57
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
30

participants targeted

Target at P25-P50 for phase_1

Timeline
Completed

Started Aug 2012

Typical duration for phase_1

Geographic Reach
1 country

6 active sites

Status
terminated

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

August 1, 2012

Completed
9 days until next milestone

First Submitted

Initial submission to the registry

August 10, 2012

Completed
6 days until next milestone

First Posted

Study publicly available on registry

August 16, 2012

Completed
2.6 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

April 1, 2015

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

April 1, 2015

Completed
Last Updated

October 29, 2015

Status Verified

October 1, 2015

Enrollment Period

2.7 years

First QC Date

August 10, 2012

Last Update Submit

October 28, 2015

Conditions

Keywords

Fecal IncontinenceBowel Incontinence

Outcome Measures

Primary Outcomes (2)

  • Effectiveness

    To assess the effectiveness of PTNS by measuring the proportion of patients with ≥50% decrease in the number of fecal incontinence episodes per week based on the results of the 14-day bowel diary at 18 weeks compared to baseline

    18 weeks

  • Safety

    To characterize adverse events experienced throughout the study

    18 weeks

Study Arms (1)

Urgent(R) PC Neuromodulation System

EXPERIMENTAL

Urgent(R) PC Neuromodulation System

Device: Urgent(R) PC Neuromodulation System

Interventions

The Urgent PC Neuromodulation System (Uroplasty, Inc., Minnetonka, MN, USA), device, is an easily administered neuromodulation system designed to deliver retrograde access to the sacral nerve through percutaneous electrical stimulation of the tibial nerve. This method of treatment is referred to as percutaneous tibial nerve stimulation (PTNS).

Urgent(R) PC Neuromodulation System

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Patient history of chronic FI of more than staining for at least 6 months; staining defined as less than the size of a 25¢ piece (quarter)
  • Patient reported and/or failed ≥ 2 conservative therapies (e.g., diet/fiber modification, anti-diarrheal medication, pelvic floor muscle training, biofeedback, medical management, etc.)

You may not qualify if:

  • Pregnancy or intention to become pregnant during the course of the study
  • Implanted electro-medical device (i.e., pacemaker, defibrillator, deep brain stimulator, etc.)
  • Clinically significant neurological diseases or nerve damage impacting tibial nerve or pelvic floor function
  • Prone to excessive bleeding or bleeding diathesis

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (6)

Kaiser Permanente Los Angeles Medical Center

Los Angeles, California, 90027, United States

Location

UCSF Center for Colorectal Surgery

San Francisco, California, 94158, United States

Location

Minnesota Colon and Rectal Surgery Associates, Ltd.

Minneapolis, Minnesota, 55407, United States

Location

The Lindner Center for Research and Education at The Christ Hospital

Cincinnati, Ohio, 45219, United States

Location

Colorectal Surgical Asociates

Houston, Texas, 77054, United States

Location

Providence Health and Services

Spokane, Washington, 99204, United States

Location

MeSH Terms

Conditions

Fecal Incontinence

Condition Hierarchy (Ancestors)

Rectal DiseasesIntestinal DiseasesGastrointestinal DiseasesDigestive System Diseases

Study Design

Study Type
interventional
Phase
phase 1
Allocation
NA
Masking
NONE
Purpose
TREATMENT
Intervention Model
SINGLE GROUP
Sponsor Type
INDUSTRY
Responsible Party
SPONSOR

Study Record Dates

First Submitted

August 10, 2012

First Posted

August 16, 2012

Study Start

August 1, 2012

Primary Completion

April 1, 2015

Study Completion

April 1, 2015

Last Updated

October 29, 2015

Record last verified: 2015-10

Locations